VANCOUVER, BC, CANADA (April 18, 2020) – Mota Ventures Corp. (CSE: FSE: 1WZ:GR OTC: PEMTF) (the “Company”) is excited to announce that for the month of March 2020, its First Class CBD brand achieved sales of Cdn$4,290,000, with related expenses of Cdn$4,240,000.  Customer acquisition expenses for March 2020 include one-time costs of approximately Cdn$1,160,000 associated with the introduction of the new line of Immune Support and CBD products.  The Immune Support product line experienced further positive growth contributing to First Class acquiring 20,959 new customers during the month of March.  The all-natural Immunity Blend is made from 100% pure essential oils, including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus, rosemary, peppermint, spearmint and oregano.  The Company also launched an Immune CBD oil, along with an Elderberry Gummy product.  The new Immune CBD product contains CBD, B3, B12, Vitamin C and Zinc. Sales for March 2020 compare to sales of Cdn$1,280,000 during the same period last year, representing an increase of 235%.

The Company also introduced a new brand, Nature’s Exclusive CBD, in the first week of April 2020.  The Nature’s Exclusive CBD brand will offer a range of products, which include the new Immune CBD oil, Elderberry gummies, CBD oil drops, CBD gummies, CBD pain relief cream, CBD skin serum and CBD coffee.

First Class offers a CBD hemp-oil formulation intended to provide users with therapeutic benefits that hemp may offer.  The hemp oil used in the products is derived from hemp grown and cultivated in the United States.  The extraction process is designed to maintain all the beneficial qualities that hemp may offer.  First Class offers a range of products, which include CBD oil drops, CBD gummies, CBD pain relief cream, CBD skin serum and CBD coffee.  First Class plans to continue its significant growth in their U.S. operations over the balance of 2020, as well as an expansion into the European market.

“I am extremely pleased with the performance of our business during March 2020, a month where the world and the economy faced immeasurable challenges.  Our ability to efficiently innovate and launch new products, is a perfect example of our primary competitive advantage, and what allows us to be a leader in the ecommerce space.

We expect our investment in accelerated customer acquisition from February to March, including a one-time cost of Cdn$1,160,000, will continue to produce significant revenue growth, and are hopeful it will lead to increased profitability in the upcoming months,” stated Ryan Hoggan, CEO of the Company.

The Company cautions that figures for revenue, expenses and margin generated from the sale of First Class CBD products have not been audited, and are based on calculations prepared by management. Actual results may differ from those reported in this release once these figures have been audited. These figures were translated from US dollars into Canadian dollars using the Bank of Canada monthly average exchange rate of US$1.00:Cdn$1.3953 for March 2020 and US$1.00:Cdn$1.3368 for March 2019.

About Mota Ventures Corp.

Mota is an established ecommerce, direct to consumer provider of a wide range of CBD products in the United States and Europe.  In the United States, the Company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its First Class CBD and Nature’s Exclusive brands.  Within Europe, its Sativida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom.  Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products.  Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.



Ryan Hoggan

Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at or

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statement

All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, including with respect to sales generated from the First Class CBD brand, the launch of new products under the First Class CBD brand, its plans to become a vertically integrated global CBD brand, its plans to cultivate and extract cannabis to produce CBD and high-quality value added CBD products in Latin America for distribution domestically and internationally and its plans to acquire revenue-producing CBD brands and operations in Europe and North America. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company’s public filings under the Company’s SEDAR profile at Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.